Chemours Co Sued by Investors Over Opteon Demand Allegations
Oct 19, 2026
A securities class action lawsuit has been filed against Chemours Co. alleging overstated Opteon product demand caused financial losses. Investors have until December 7, 2026, to join as lead plaintiffs.
Show all 33 updates